Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2007-4-26
pubmed:abstractText
The clinical relevance of polychemotherapy in osteosarcoma is undisputed and well proven. In this retrospective study we report the results of chemotherapy treatment without high-dose methotrexate (HDMTX) for osteosarcoma.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0378-584X
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
228-32
pubmed:meshHeading
pubmed-meshheading:17460416-Adolescent, pubmed-meshheading:17460416-Adult, pubmed-meshheading:17460416-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17460416-Bone Neoplasms, pubmed-meshheading:17460416-Chemotherapy, Adjuvant, pubmed-meshheading:17460416-Child, pubmed-meshheading:17460416-Combined Modality Therapy, pubmed-meshheading:17460416-Dose-Response Relationship, Drug, pubmed-meshheading:17460416-Drug Administration Schedule, pubmed-meshheading:17460416-Female, pubmed-meshheading:17460416-Follow-Up Studies, pubmed-meshheading:17460416-Humans, pubmed-meshheading:17460416-Limb Salvage, pubmed-meshheading:17460416-Male, pubmed-meshheading:17460416-Methotrexate, pubmed-meshheading:17460416-Neoadjuvant Therapy, pubmed-meshheading:17460416-Neoplasm Staging, pubmed-meshheading:17460416-Osteosarcoma, pubmed-meshheading:17460416-Survival Rate
pubmed:year
2007
pubmed:articleTitle
Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
pubmed:affiliation
Department of Surgery and Surgical Oncology, Campus Buch, Robert Rössle Hospital, elios Klinikum, Charité University Medicine Berlin, Germany. per-ulf.tunn@charite.de
pubmed:publicationType
Journal Article